查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1736712

2026 年至 2032 年製药废弃物管理市场规模（按废弃物类型、废弃物性质、最终用户和地区划分）

Pharmaceutical Waste Management Market Size By Waste Type, Nature of Waste, End-User & Region for 2026-2032
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

製药废弃物管理市场评估-2026-2032

由于人口增长和医疗设施扩张，全球范围内产生的药物废弃物日益增多，已成为一个重大问题。人们越来越意识到不当药物废弃物处置带来的环境和健康风险。为了减少此类危害，同时确保环境永续性，人们越来越重视适当的药物废弃物管理，这将推动市场规模在2024年突破16,623.5亿美元，并在2032年达到约26,315.9亿美元的估值。

此外，政府和环保组织对药物废弃物处置实施的严格规定和准则正在推动对有效药物废弃物管理解决方案的需求。为了减少药物废弃物的不利影响，监管机构越来越注重确保安全和无害环境的处置。此外，药物废弃物管理市场受到越来越多采用先进技术的推动，例如高温焚烧、掩埋以及化学处理和高压釜等非焚烧方法。这些方法有助于安全处置和销毁药物废弃物，减少与不当处置相关的环境和健康问题。由于对药物废弃物管理的需求不断增长，市场将从 2026 年到 2032 年以 5.91% 的复合年增长率成长。

製药废弃物管理市场定义/概述

药物废弃物管理是指对药品生命週期内产生的各类药物废弃物进行安全有效的处置。这些废弃物包括过期或未使用的药品、受污染的包装以及药品生产、分销和管理过程中使用的其他物品。药物废弃物管理的目标是减少因处置不当而造成的环境和健康问题，以及对人体的潜在危害。

药物废弃物管理用于各种环境，例如製药厂、医院、诊所、药局、研究机构等。这些组织产生大量的药物废弃物，包括过期和未使用的药品、受污染的包装、实验室化学品等。适当的废弃物管理对于满足环境要求、减少污染和保护公众健康至关重要。

医疗废弃物的增加将如何推动医药废弃物管理市场？

全球製药业正在迅速扩张，导致废弃物排放不断增加。根据IQVIA人类数据科学研究所的数据，预计到2026年，全球医药支出将达到1.8兆美元，复合年增长率为3-6%。根据世界卫生组织（WHO）的数据，到2020年，全球药品产量将从1985年的3,000亿单位成长十倍，达到3兆单位以上。这种扩张直接导致需要有效处置的製药废弃物增加。

为了因应日益严重的环境问题，世界各国政府正在颁布更严格的药品废弃物处理法律。根据美国环保署 (EPA) 统计，美国超过 7,000 家医疗机构每年排放超过 14,000 吨危险药品废弃物。根据欧洲药品管理局 (EMA) 统计，欧盟 (EU) 88% 的新药申请需要进行环境风险评估，高于 2005 年的 10%。

此外，公众对不当药品处置带来的环境和健康危害的认识不断提高，这也推动了市场的成长。发表在《环境毒理学与化学》杂誌上的一项研究发现，93种最常见配方药物中，88%的药物在地表水、地下水和饮用水中都以微量存在。根据美国地质调查局的数据，80%的美国河流中含有微量药物。这种认知促使人们开展更多妥善处置药物的项目，例如美国缉毒局的“全国处方药回收日”，仅在2021年10月就收集了744,082磅不需要的处方药。

高资本投入会阻碍製药废弃物管理市场吗？

成功管理药物废弃物所需的巨额资本支出是医院、医疗机构和製药公司面临的一大障碍。这些机构必须投入大量资金，建立符合环保要求并减少污染的先进废弃物管理系统。这些系统成本高昂，需要先进的技术来收集、处理和处置危险和非危险药物废弃物，这给这些机构的预算带来了沉重的负担。

药物废弃物管理所需的高昂资本成本，对小型医疗机构和製药公司构成了进入壁垒，阻碍了市场扩张。小型企业无力负担实施现代化废弃物管理技术所需的高昂前期成本，因此选择成本较低、效率较低的方案或错误的处置技术。这加剧了环境污染，危及公众健康，与药物废弃物管理的目标背道而驰。

目录

第一章 引言

  • 市场定义
  • 市场区隔
  • 调查时间表
  • 先决条件
  • 限制

第二章调查方法

  • 资料探勘
  • 二次研究
  • 初步研究
  • 专家建议
  • 品质检查
  • 最终审核
  • 数据三角测量
  • 自下而上的方法
  • 自上而下的方法
  • 调查流程
  • 资料来源

第三章执行摘要

  • 全球製药废弃物管理市场概览
  • 全球製药废弃物管理绝对商机
  • 全球製药废弃物管理市场吸引力（按地区）
  • 全球製药废弃物管理市场（按地区）分析
  • 全球製药废弃物管理市场（按废弃物类型）
  • 全球製药废弃物管理市场（按废弃物类型）
  • 全球製药废弃物管理市场（按最终用户划分）
  • 未来市场机会
  • 全球市场区隔

第四章 市场展望

  • 全球製药废弃物管理市场展望
  • 市场驱动因素
    • 政府越来越多地采取适当措施处理药品
    • 战后婴儿潮世代的崛起
  • 限制因素
    • 缺乏对药品不当处置影响的认识
    • 废弃物处理成本高昂
  • 可能性
    • 世界各地研究和开发活动活性化。
  • COVID-19 对全球製药废弃物管理市场的影响
  • 宏观经济分析
  • 波特五力分析
    • 新进入者的威胁
    • 替代品的威胁
    • 供应商的议价能力
    • 买家的议价能力
    • 竞争对手之间的竞争强度
  • 价值链分析

第五章废弃物类型市场

  • 概述
  • 危险医药废弃物
  • 无害医药废弃物

第六章废弃物类型市场

  • 概述
  • 非处方药废弃物
  • 不受管制的处方药
  • 管制药物
  • 危险药物

第七章 终端用户市场

  • 概述
  • 医院
  • 製药公司
  • 製药和生物技术公司
  • 诊所和诊所
  • 其他的

第八章 区域市场

  • 概述
  • 北美洲
    • 北美市场概述
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲市场概述
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 亚太市场概述
    • 中国
    • 印度
    • 日本
    • 其他亚太地区
  • 拉丁美洲
    • 拉丁美洲市场概述
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 中东和非洲市场概述
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

第九章 竞争态势

  • 概述
  • 各公司市场排名分析
  • 区域足迹
  • 公司在各行业的足迹

第十章 公司简介

  • STERICYCLE
  • DANIELS HEALTH
  • WASTE MANAGEMENT INC.
  • CARDINAL HEALTH, INC.
  • COVANTA HOLDING CORPORATION
  • US ECOLOGY, INC.
  • BIOMEDICAL WASTE SOLUTION LLC
  • BECTON, DICKINSON AND COMPANY
  • STRYKER
  • 医疗废弃物服务
Product Code: 40255

Pharmaceutical Waste Management Market Valuation - 2026-2032

The increasing volume of pharmaceutical waste generated globally owing mostly to population growth and improved healthcare facilities is a major concern. People are becoming more aware of the environmental and health risks associated with inappropriate pharmaceutical waste disposal. There is an increasing emphasis on proper pharmaceutical waste management to reduce these dangers while also ensuring environmental sustainability by enabling the market to surpass a revenue of USD 1662.35 Billion valued in 2024 and reach a valuation of around USD 2631.59 Billion by 2032.

Furthermore, severe rules and guidelines enforced by governments and environmental organizations governing pharmaceutical waste disposal are driving up the demand for effective pharmaceutical waste management solutions. To reduce the negative consequences of pharmaceutical waste, regulatory organizations are increasingly focusing on ensuring its safe and environmentally appropriate disposal. In addition, the pharmaceutical waste management market is being driven by the increasing adoption of advanced technologies such as high-temperature incineration, landfilling, and non-incineration methods such as chemical treatments and autoclaves. These methods facilitate the safe disposal and destruction of pharmaceutical waste lowering the environmental and health concerns associated with inappropriate disposal. The growing need for pharmaceutical waste management by enabling the market to grow at a CAGR of 5.91% from 2026 to 2032.

Pharmaceutical Waste Management Market: Definition/ Overview

Pharmaceutical waste management is the safe and efficient disposal of various types of pharmaceutical waste created during the lifecycle of pharmaceutical products. This waste consists of expired or unused medications, contaminated packaging, and other items used in the production, distribution, and administration of pharmaceuticals. The goal of pharmaceutical waste management is to reduce the environmental and health concerns associated with inappropriate disposal as well as potential harm to human health.

Pharmaceutical waste management is used in a variety of settings including pharmaceutical production plants, hospitals, clinics, pharmacies, and research organizations. These organizations generate a substantial amount of pharmaceutical waste which includes expired or unused pharmaceuticals, contaminated packaging, and laboratory chemicals. Proper waste management is critical to meeting environmental requirements, reducing pollution, and protecting public health.

How Does the Increasing Volume of Healthcare Waste Drive the Pharmaceutical Waste Management Market?

The global pharmaceutical business is rapidly expanding, resulting in increased waste output. According to the IQVIA Institute for Human Data Science, global pharmaceutical spending is expected to reach USD 1.8 Trillion by 2026, increasing at a 3-6% compound annual growth rate. According to the World Health Organization (WHO), global pharmaceutical production has expanded from 300 billion Standard Units in 1985 to more than 3 trillion Standard Units in 2020, a 10-fold increase. This expansion directly adds to the increasing volume of pharmaceutical waste that requires effective disposal.

Governments around the world are enacting harsher laws for pharmaceutical waste disposal in response to growing environmental concerns. According to the Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. According to the European Medicines Agency (EMA), environmental risk evaluations are now needed for 88% of new drug applications in the European Union, up from 10% in 2005, resulting in increased demand for proper waste management solutions.

Furthermore, the growing public awareness of the environmental and health dangers connected with inappropriate medication disposal is propelling market growth. A study published in Environmental Toxicology and Chemistry discovered that 88% of the 93 most often prescribed medications can be found in trace levels in surface, ground, and drinking water. According to the US Geological Survey, 80% of US streams contain trace levels of human pharmaceuticals. This awareness is prompting additional programs for proper disposal, such as the United States Drug Enforcement Administration's National Prescription Drug Take Back Day, which gathered 744,082 pounds of unneeded prescription medicines in October 2021 alone.

How Does the High Capital Investment Hamper the Pharmaceutical Waste Management Market?

The large capital expenditure necessary for successful pharmaceutical waste management presents a substantial barrier for hospitals, healthcare institutes, and pharmaceutical corporations. These organizations must devote significant financial resources to creating sophisticated waste management systems that comply with environmental requirements and reduce pollution. The high expense of these systems which involve advanced technologies for collecting, processing, and disposing of both hazardous and non-hazardous pharmaceutical waste put a burden on these institutions' budgets.

The high capital requirements for pharmaceutical waste management stifle market expansion by acting as a barrier to entry for smaller healthcare facilities and pharmaceutical corporations. Smaller businesses are unable to afford the large upfront expenses associated with deploying modern waste management technology and instead choose cheaper, less effective options or incorrect disposal techniques. This increases environmental contamination and endangers public health contradicting the goals of pharmaceutical waste management.

Category-Wise Acumens

How Do Increased Procedures Related to Chronic Diseases Drive the Hazardous Pharmaceutical Waste?

The hazardous segment is estimated to dominate the pharmaceutical waste management market. Chronic diseases such as cancer, diabetes, cardiovascular disease, and respiratory disorders frequently necessitate extensive and long-term medical interventions such as surgeries, chemotherapy, radiation therapy, and medication. These treatments produce a large amount of hazardous medical waste which includes contaminated sharps, chemotherapeutic medications, pathological waste, and infectious materials.

As the global frequency of chronic diseases increases due to reasons such as aging populations, sedentary lifestyles, and unhealthy dietary habits, so does the volume of hazardous medical waste generated. The increasing number of healthcare operations associated with chronic diseases is likely to have a major impact on the hazardous waste segment of the medical waste management market. Healthcare facilities such as hospitals, clinics, and specialized treatment centers must consequently establish appropriate waste management systems to properly and efficiently manage the rising volume of hazardous medical waste.

Furthermore, proper treatment of hazardous medical waste created during chronic disease operations is critical to maintaining public health and environmental safety. The regulatory rules for waste management are being edited and tightened to address the issues provided by the growing volume of hazardous medical waste. As a result, healthcare facilities are rapidly investing in innovative waste management technology and solutions to comply with these laws while reducing the environmental and health concerns connected with hazardous medical waste.

How do the Increasing Awareness and New Technologies Drive the Hospitals in the Market?

Hospitals accounted for the largest market share due to rising awareness campaigns and the introduction of new technologies. The healthcare industry is becoming more conscious of the necessity of effective medical waste management for maintaining public health and environmental safety. As a result, there has been an increase in awareness campaigns, conferences, and training sessions centered on new technology and best practices for medical waste management.

Furthermore, the introduction of new medical waste management technologies is critical to boosting the growth of the hospital and diagnostic laboratory markets. Healthcare facilities are progressively using advanced technologies to manage medical waste safely and efficiently, such as autoclaving, microwave treatment, steam sterilization, and chemical disinfection. These technologies have various benefits such as improved waste sterilization, less environmental impact, and cheaper operational costs. As a result, hospitals, diagnostic laboratories, and other healthcare facilities are expanding their investments in modern technologies to improve waste management.

Furthermore, the increasing emphasis on regulatory compliance and environmental sustainability is encouraging healthcare organizations to invest in innovative medical waste management technologies. Regulatory bodies are enforcing stricter norms and regulations for medical waste management and treatment to reduce environmental pollution and public health threats. As a result, rising awareness and the introduction of new technologies are likely to propel the end-user segment particularly hospitals and diagnostic laboratories into the medical waste management market.

Country/Region-wise Acumens

How will the Increasing Adoption of Pharmaceutical Waste Management Services Drive the Market in North America?

North America is estimated to dominate the pharmaceutical waste management market during the forecast period. North America, particularly the United States, has one of the most severe regulatory regimes for managing pharmaceutical waste. According to the US Environmental Protection Agency (EPA), over 7,000 healthcare facilities in the United States generate over 14,000 tons of hazardous pharmaceutical waste each year. The Resource Conservation and Recovery Act (RCRA) and the Hazardous Waste Pharmaceuticals Rule, which were enacted in 2019, established tight standards for pharmaceutical waste treatment, resulting in market growth in this region.

Furthermore, North Americans are becoming more conscious of the proper disposal of unused or expired drugs. The Drug Enforcement Administration's (DEA) National Prescription Drug Take Back Day has witnessed a considerable turnout. The DEA stated in 2021 that their Take Back Day programs had gathered a total of 15,989,566 pounds (more than 7,995 tons) of prescription medicines since the program's commencement in 2010. This increased awareness and engagement in such programs is generating demand for pharmaceutical waste management services in the region.

Will the Growing Prevalence of Chronic Diseases Boost the Market in the European Region?

Europe region is estimated to exhibit substantial growth within the market during the forecast period. Europe has enacted stringent laws for pharmaceutical waste treatment, resulting in market growth. The European Commission's 2020 pharmaceutical plan intends to minimize the environmental effect of medicines by 30% by 2030. According to the European Medicines Agency (EMA), 88% of new medicine applications in the European Union now include an environmental risk assessment, up from 10% in 2005. This regulatory climate compels pharmaceutical businesses and healthcare facilities to invest in effective waste management solutions.

Furthermore, Europe has a high incidence of pharmaceutical use, which can be attributed in part to its aging population. According to Eurostat data, the proportion of people aged 65 and over is expected to rise from 20.3% in 2019 to 29.4% by 2050. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the European pharmaceutical market is estimated to be worth €213.4 billion in 2020. This high consumption rate, along with an aging population that normally requires more prescriptions, creates a substantial amount of pharmaceutical waste that must be properly managed.

Competitive Landscape

The pharmaceutical waste management market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations focus on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the pharmaceutical waste management market include:

Cardinal Health

Covanta Holding Corporation

US Ecology, Inc.

Stericycle

BioMedical Waste Solution LLC

Dickinson and Company

Waste Management, Inc.

Daniels Health

Sharps Compliance, Inc.

Stryker

Becton

Latest Developments

In February 2021, Cardinal Health WaveMark(TM) Supply Management & Workflow Solutions partnered with HIMSS Analytics(R), a Certified Organization of the Clinically Integrated Supply Outcomes Model (CISOM), to help healthcare systems optimize and benchmark their progress in clinical and operational supply chains.

In February 2023, EcoSteris announced the development of a cutting-edge medical waste plant in Summerville, creating a unique and creative footprint in the business.

In May 2021, UPS Healthcare and Stericycle formed an ongoing relationship to manage medical waste reverse logistics, including trash classification and disposal. UPS and Stericycle hope to provide comprehensive logistical support to the healthcare industry as a result of their collaboration.

Pharmaceutical Waste Management Market, By Category

  • Type of Waste:
  • Over the counter Waste
  • Non-controlled Prescription Drugs
  • Controlled Drugs
  • Hazardous Drugs
  • Nature of Waste:
  • Hazardous Pharmaceutical Waste
  • Non-hazardous Pharmaceutical Waste
  • End User:
  • Hospitals
  • Pharmacies
  • Pharmaceutical & Biotechnology Companies
  • Clinics & Physicians' Offices
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP-DOWN APPROACH
  • 2.1 RESEARCH FLOW
  • 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

  • 3.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OVERVIEW
  • 3.2 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT ABSOLUTE MARKET OPPORTUNITY
  • 3.3 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET ATTRACTIVENESS, BY REGION
  • 3.4 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
  • 3.5 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE (USD MILLION)
  • 3.6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE (USD MILLION)
  • 3.7 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER (USD MILLION)
  • 3.8 FUTURE MARKET OPPORTUNITIES
  • 3.9 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

  • 4.1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OUTLOOK
  • 4.2 MARKET DRIVERS
    • 4.2.1 INCREASING GOVERNMENT INITIATIVES FOR PROPER DISPOSAL OF MEDICATIONS
    • 4.2.2 INCREASING NUMBERS OF THE BOOMER GENERATION
  • 4.3 RESTRAINTS
    • 4.3.1 LACK OF AWARENESS ABOUT THE IMPACTS OF IMPROPER DISPOSAL OF MEDICATIONS
    • 4.3.2 HIGH COSTS ASSOCIATED WITH THIS WASTE MANAGEMENT
  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES ACROSS THE GLOBE TO SUPPORT
  • 4.5 IMPACT OF COVID19 ON GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET
  • 4.6 MACROECONOMIC ANALYSIS
  • 4.7 PORTER'S FIVE FORCES ANALYSIS
    • 4.7.1 THREAT OF NEW ENTRANTS
    • 4.7.2 THREAT OF SUBSTITUTES
    • 4.7.3 BARGAINING POWER OF SUPPLIERS
    • 4.7.4 BARGAINING POWER OF BUYERS
    • 4.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 4.8 VALUE CHAIN ANALYSIS

5 MARKET, BY NATURE OF WASTE

  • 5.1 OVERVIEW
  • 5.2 HAZARDOUS PHARMACEUTICAL WASTE
  • 5.3 NON-HAZARDOUS PHARMACEUTICAL WASTE

6 MARKET, BY TYPE OF WASTE

  • 6.1 OVERVIEW
  • 6.2 OVER THE COUNTER WASTE
  • 6.3 NON-CONTROLLED PRESCRIPTION DRUGS
  • 6.4 CONTROLLED DRUGS
  • 6.5 HAZARDOUS DRUGS

7 MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS
  • 7.3 PHARMACIES
  • 7.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 7.5 CLINICS & PHYSICIANS' OFFICE
  • 7.6 OTHERS

8 MARKET, BY GEOGRAPHY

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 NORTH AMERICA MARKET SNAPSHOT
    • 8.2.2 U.S.
    • 8.2.3 CANADA
    • 8.2.4 MEXICO
  • 8.3 EUROPE
    • 8.3.1 EUROPE MARKET SNAPSHOT
    • 8.3.2 GERMANY
    • 8.3.3 U.K.
    • 8.3.4 FRANCE
    • 8.3.5 ITALY
    • 8.3.6 SPAIN
    • 8.3.7 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 ASIA PACIFIC MARKET SNAPSHOT
    • 8.4.2 CHINA
    • 8.4.3 INDIA
    • 8.4.4 JAPAN
    • 8.4.5 REST OF ASIA PACIFIC
  • 8.5 LATIN AMERICA
    • 8.5.1 LATIN AMERICA MARKET SNAPSHOT
    • 8.5.2 BRAZIL
    • 8.5.3 ARGENTINA
    • 8.5.4 REST OF LATIN AMERICA
  • 8.6 MIDDLE EAST AND AFRICA
    • 8.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
    • 8.6.2 UAE
    • 8.6.3 SAUDI ARABIA
    • 8.6.4 SOUTH AFRICA
    • 8.6.5 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPANY MARKET RANKING ANALYSIS
  • 9.3 COMPANY REGIONAL FOOTPRINT
  • 9.4 COMPANY INDUSTRY FOOTPRINT

10 COMPANY PROFILES

  • 10.1 STERICYCLE
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 COMPANY INSIGHTS
    • 10.1.3 PRODUCT BENCHMARKING
    • 10.1.4 WINNING IMPERATIVES
    • 10.1.5 CURRENT FOCUS & STRATEGIES
    • 10.1.6 THREAT FROM COMPETITION
    • 10.1.7 SWOT ANALYSIS
  • 10.2 DANIELS HEALTH
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 COMPANY INSIGHTS
    • 10.2.3 PRODUCT BENCHMARKING
    • 10.2.4 WINNING IMPERATIVES
    • 10.2.5 CURRENT FOCUS & STRATEGIES
    • 10.2.6 THREAT FROM COMPETITION
    • 10.2.7 SWOT ANALYSIS
  • 10.3 WASTE MANAGEMENT INC.
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 COMPANY INSIGHTS
    • 10.3.3 PRODUCT BENCHMARKING
    • 10.3.4 WINNING IMPERATIVES
    • 10.3.5 CURRENT FOCUS & STRATEGIES
    • 10.3.6 THREAT FROM COMPETITION
    • 10.3.7 SWOT ANALYSIS
  • 10.4 CARDINAL HEALTH, INC.
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 COMPANY INSIGHTS
    • 10.4.3 SEGMENT BREAKDOWN
    • 10.4.4 PRODUCT BENCHMARKING
  • 10.5 COVANTA HOLDING CORPORATION
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 COMPANY INSIGHTS
    • 10.5.3 PRODUCT BENCHMARKING
  • 10.6 US ECOLOGY, INC.
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 COMPANY INSIGHTS
    • 10.6.3 PRODUCT BENCHMARKING
  • 10.7 BIOMEDICAL WASTE SOLUTION LLC
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 COMPANY INSIGHTS
    • 10.7.3 PRODUCT BENCHMARKING
  • 10.8 BECTON, DICKINSON AND COMPANY
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 COMPANY INSIGHTS
    • 10.8.3 SEGMENT BREAKDOWN
    • 10.8.4 PRODUCT BENCHMARKING
  • 10.9 STRYKER
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 COMPANY INSIGHTS
    • 10.9.3 PRODUCT BENCHMARKING
  • 10.10 MEDICAL WASTE SERVICE
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 COMPANY INSIGHTS
    • 10.10.3 PRODUCT BENCHMARKING

LIST OF TABLES

  • TABLE1 MOST FREQUENTLY USED PHARMACEUTICALS THAT ARE DETECTED IN WASTEWATERS.
  • TABLE 2 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
  • TABLE 3 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 4 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 5 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY GEOGRAPHY, 2022-2030 (USD MILLION)
  • TABLE 7 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 8 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 9 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE10 NORTH AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE11 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE12 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE13 U.S. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE14 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE15 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE16 CANADA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE17 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE18 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE19 MEXICO PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 20 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 21 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 22 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 23 EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 24 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 25 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 26 GERMANY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 27 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 28 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 29 U.K. PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 30 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 31 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 32 FRANCE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 33 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 34 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 35 ITALY PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 36 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 37 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 38 SPAIN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 39 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 40 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 41 REST OF EUROPE PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 42 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 43 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 44 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 45 ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 46 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 47 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 48 CHINA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 49 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 50 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 51 INDIA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 52 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 53 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 54 JAPAN PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 55 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 56 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE, 2022-2030 (USD MILLION)
  • TABLE 57 REST OF ASIA PACIFIC PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER, 2022-2030 (USD MILLION)
  • TABLE 58 LATIN AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY COUNTRY, 2022-2030 (USD MILLION)
  • TABLE 59 LATIN AMERICA PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE, 2022-2030 (USD MILLION)

LIST OF FIGURES

  • FIGURE1 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2 RESEARCH TIMELINES
  • FIGURE 3 DATA TRIANGULATION
  • FIGURE 4 MARKET RESEARCH FLOW
  • FIGURE 5 DATA SOURCES
  • FIGURE 6 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS, 2023-30
  • FIGURE 7 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE (USD MILLION)
  • FIGURE 8 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE (USD MILLION)
  • FIGURE 9 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER (USD MILLION)
  • FIGURE10 FUTURE MARKET OPPORTUNITIES
  • FIGURE11 NORTH AMERICA DOMINATED THE MARKET IN 2021
  • FIGURE12 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET OUTLOOK
  • FIGURE13 ANNUAL INCREASE IN THE RETIRED U.S. BABY BOOMER POPULATION (IN MILLIONS)
  • FIGURE14 ANNUAL R&D SPENDING BY PHRMA MEMBER FIRMS (IN BILLIONS OF 2019 DOLLARS)
  • FIGURE15 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE16 VALUE CHAIN ANALYSIS
  • FIGURE17 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY NATURE OF WASTE
  • FIGURE18 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY TYPE OF WASTE
  • FIGURE19 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY END USER
  • FIGURE 20 GLOBAL PHARMACEUTICAL WASTE MANAGEMENT MARKET, BY GEOGRAPHY, 2022-2030 (USD MILLION)
  • FIGURE 21 U.S. PHARMACEUTICAL R&D EXPENDITURE, 2000-2019 (USD MILLION)
  • FIGURE 22 U.S. MARKET SNAPSHOT
  • FIGURE 23 CANADA MARKET SNAPSHOT
  • FIGURE 24 MEXICO MARKET SNAPSHOT
  • FIGURE 25 PHARMACEUTICAL PRODUCTION IN EUROPE, 2019 (EUROS MILLION)
  • FIGURE 26 GERMANY MARKET SNAPSHOT
  • FIGURE 27 U.K. MARKET SNAPSHOT
  • FIGURE 28 FRANCE MARKET SNAPSHOT
  • FIGURE 29 ITALY MARKET SNAPSHOT
  • FIGURE 30 SPAIN MARKET SNAPSHOT
  • FIGURE 31 REST OF EUROPE MARKET SNAPSHOT
  • FIGURE 32 CHINA MARKET SNAPSHOT
  • FIGURE 33 INDIA MARKET SNAPSHOT
  • FIGURE 34 JAPAN MARKET SNAPSHOT
  • FIGURE 35 REST OF ASIA PACIFIC MARKET SNAPSHOT
  • FIGURE 36 BRAZIL MARKET SNAPSHOT
  • FIGURE 37 ARGENTINA MARKET SNAPSHOT
  • FIGURE 38 REST OF LATIN AMERICA MARKET SNAPSHOT
  • FIGURE 39 UAE MARKET SNAPSHOT
  • FIGURE 40 SAUDI ARABIA MARKET SNAPSHOT
  • FIGURE 41 SOUTH AFRICA MARKET SNAPSHOT
  • FIGURE 42 REST OF MIDDLE EAST AND AFRICA MARKET SNAPSHOT
  • FIGURE 43 KEY STRATEGIC DEVELOPMENTS
  • FIGURE 44 STERICYCLE: COMPANY INSIGHT
  • FIGURE 45 STERICYCLE: SWOT ANALYSIS
  • FIGURE 46 DANIELS HEALTH: COMPANY INSIGHT
  • FIGURE 47 DANIELS HEALTH: SWOT ANALYSIS
  • FIGURE 48 WASTE MANAGEMENT INC.: COMPANY INSIGHT
  • FIGURE 49 WASTE MANAGEMENT INC.: SWOT ANALYSIS
  • FIGURE 50 CARDINAL HEALTH, INC.: COMPANY INSIGHT
  • FIGURE 51 CARDINAL HEALTH, INC.: SEGMENT BREAKDOWN
  • FIGURE 52 COVANTA HOLDING CORPORATION: COMPANY INSIGHT
  • FIGURE 53 US ECOLOGY, INC.: COMPANY INSIGHT
  • FIGURE 54 BIOMEDICAL WASTE SOLUTION LLC: COMPANY INSIGHT
  • FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY INSIGHT
  • FIGURE 56 CARDINAL HEALTH, INC.: SEGMENT BREAKDOWN
  • FIGURE 57 STRYKER: COMPANY INSIGHT
  • FIGURE 58 MEDICAL WASTE SERVICE: COMPANY INSIGHT